Do stimulants, such as caffeine or Adderall (amphetamine and dextroamphetamine), increase the risk of atrial fibrillation (AFib)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Stimulants and Atrial Fibrillation Risk

Stimulants such as amphetamines (including Adderall) can increase the risk of atrial fibrillation, while moderate caffeine consumption does not appear to significantly increase risk in most individuals. 1

Amphetamine-Based Stimulants (Adderall)

Risk Profile

  • Amphetamines are explicitly listed in clinical guidelines as medications that may cause elevated blood pressure and potentially trigger cardiac arrhythmias including atrial fibrillation 1
  • The 2017 ACC/AHA guidelines specifically identify amphetamines (including amphetamine, methylphenidate, dexmethylphenidate, and dextroamphetamine) as substances that can impair blood pressure control 1

Management Recommendations

  • For patients with or at risk for atrial fibrillation who are taking amphetamine-based stimulants:
    • Discontinue or decrease dose when possible 1
    • Consider behavioral therapies as alternatives for ADHD management 1
    • Monitor for symptoms of palpitations, shortness of breath, dizziness, or chest pain which may indicate arrhythmia development 1

Caffeine

Risk Profile

  • Unlike amphetamines, caffeine has not been strongly linked to increased risk of atrial fibrillation in most individuals 2, 3
  • Current evidence suggests that moderate caffeine consumption does not increase the incidence of atrial fibrillation 3
  • Some research even suggests a potentially lower incidence of atrial fibrillation with caffeine consumption exceeding 436 mg/day 3

Management Recommendations

  • Guidelines suggest generally limiting caffeine intake to <300 mg/day 1
  • Avoid use in patients with uncontrolled hypertension 1
  • Be aware that while coffee consumption is associated with acute increases in blood pressure, long-term use has not been associated with increased blood pressure or cardiovascular disease 1

Special Considerations

Energy Drinks

  • High-dose caffeine products like energy drinks may pose greater risk than regular coffee 4, 5
  • Case reports document atrial fibrillation and atrial flutter in young, otherwise healthy individuals following energy drink consumption 4, 5
  • These products often contain additional stimulants beyond caffeine that may compound cardiovascular effects

Risk Factors for Stimulant-Induced Atrial Fibrillation

Patients with the following factors may be at higher risk for stimulant-induced arrhythmias 1, 6:

  • Previous history of atrial fibrillation
  • Advanced age
  • Hypertension
  • Coronary artery disease
  • Left atrial enlargement
  • Premature atrial beats

Clinical Approach

  1. For patients with or at risk for atrial fibrillation:

    • Recommend discontinuation or dose reduction of amphetamine-based stimulants
    • Moderate caffeine consumption (below 300 mg/day) is generally acceptable
    • Strongly advise against energy drink consumption
    • Consider alternative non-stimulant treatments for ADHD when possible
  2. For patients experiencing new-onset atrial fibrillation:

    • Assess for stimulant use, including prescription medications, over-the-counter products, and energy drinks
    • Discontinuation of the offending agent may lead to resolution in some cases
  3. For patients requiring stimulants for medical conditions:

    • Use the lowest effective dose
    • Monitor cardiac parameters regularly
    • Consider ECG monitoring in high-risk patients

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Atrial Fibrillation Due to Over The Counter Stimulant Drugs in A Young Adult.

Journal of clinical and diagnostic research : JCDR, 2015

Research

Case Report Stimulant-Induced Atrial Flutter in a Remote Setting.

Journal of special operations medicine : a peer reviewed journal for SOF medical professionals, 2020

Guideline

Atrial Fibrillation Risk Factors

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.